Novartis Pharmaceuticals Corporation, East Hanover, Nj Federal Communications Commission
As part of the deal, Cambrian was setting up a subsidiary named Tornado Therapeutics. In October Novartis announced it would acquire Vedere Bio for $280 million boosting the companies cell and gene therapy offerings. In November 2016, the organization announced it would obtain Selexys Pharmaceuticals for $665 million. In December, the firm acquired Encore Vision, gaining the company’s principle compound, EV06, is a initially-in-class topical therapy for presbyopia. In December Novartis acquired Ziarco Group Limited, bolstering its presence in eczema…